UiPath Stock Gains 33% in 6 Months: Should You Buy, Hold or Fold?

UiPath (PATH) has gained 33% over six months, driven by expanding AI capabilities through its Maestro platform and improving profitability. Q2 revenues rose 13% to $410M with ARR climbing 12% to $1.94B. Trading at a forward P/E of 15.29 versus the industry average of 30.92, PATH appears undervalued. However, intensifying competition and uncertain enterprise spending pose risks to growth.